Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Yкраїнський (UK)
Przejdź do strony domowej biblioteki Centralna Biblioteka Wojskowa Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaCentralna Biblioteka Wojskowa

Wyszukujesz frazę "Meniere disease" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-7 z 7
    Tytuł:
    Meniere Disease p. 1. Diagnosis criteria, signs and symptoms of Meniere Disease (MD) – comment to updated guidelines and own experiences
    Autorzy:
    Niemczyk, Kazimierz
    Pierchała, Katarzyna
    Bartoszewicz, Robert
    Jasińska, Agnieszka
    Powiązania:
    https://bibliotekanauki.pl/articles/1399343.pdf
    Data publikacji:
    2019
    Wydawca:
    Index Copernicus International
    Tematy:
    hearing loss
    inner ear
    Meniere’s disease
    tinnitus
    tone audiometry
    vertigo
    Opis:
    We present an overview of current diagnostic and therapeutic guidelines on Ménière’s disease. Over the last five years, four studies on this subject have been published. In 2015, five Societies including the Classification Committee of the Barany Society, Japan Society for Equilibrium Research, EAONO - European Academy of Otology and Neurotology, AAO-HNS - American Academy of Otorhinolaryngology - Head Neck Surgery, and Korean Balance Society have issued updated guidelines on the diagnosis and treatment of Ménière’s disease. Other multi-center publications have since been published as well such as the International consensus (ICON) on treatment of Ménière’s disease 2018, European Position Statement on Diagnosis, and Treatment of Meniere’s Disease, Diagnostic and therapeutic strategy in Ménière’s disease, Guidelines of the French Otorhinolaryngology - Head and Neck Surgery Society (SFORL) 2017. The above-listed recommendations include the most recent diagnostic advancements (e.g. inner ear MRI) and new electrophysiological tests, but also discuss other commonly used treatment modalities, result reporting and they take into account the quality of life of the patients following treatment. We present the main clinical challenges in managing Ménière’s disease, principles of diagnosis as well as the treatment introduced at our center. Finally, we discuss fundamental updates contained in the published papers.
    Źródło:
    Polski Przegląd Otorynolaryngologiczny; 2019, 8, 2; 12-17
    2084-5308
    2300-7338
    Pojawia się w:
    Polski Przegląd Otorynolaryngologiczny
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Persistence of Non-Vertigo Symptoms in Meniere Disease During Remission – A Preliminary Report
    Autorzy:
    Olusesi, Abiodun
    Oyeniran, Olubukola
    Powiązania:
    https://bibliotekanauki.pl/articles/1397442.pdf
    Data publikacji:
    2020
    Wydawca:
    Index Copernicus International
    Tematy:
    Meniere disease
    Non-Vertigo Symptoms
    remission
    Opis:
    Background: Though the absence of vertigo in Meniere disease is often interpreted as remission, patient-centered subjective assessment of quality of life remains the best indicator of such remission. Study Objective: To assess the presence and severity of aural pressure/tinnitus, hearing loss, unsteadiness, nausea and vomiting in MD patients during remission. Setting: Urban tertiary care referral hospital in a developing country. Methodology: Consecutive patients with diagnosis of Definite Meniere were selected from the Balance and Dizziness Clinic of National Hospital Abuja for the study. Quality of life assessment was carried out using 3 validated tools – Modified MD-POSI, Vertigo Symptom Scale and Tinnitus Handicap Inventory (THI). Patients were included only when they have been vertigo free for at least 4 weeks. Pure tone audiometry was carried out in those with subjective hearing loss at recruitment and 4 weeks later. Results: A total of 26 patients completed the study. All had cinnarizine for acute vertigo control and Betahistine for maintenance of vertigo control. There was female preponderance (17:9). The age range was 32–56 years. The duration of MD ranges from 4 months to 12 years. The total and subscale MD-POSI scores for “between attacks” significantly correlated with hearing, unsteadiness and tinnitus/pressure when compared to during attack. 69.2 per cent of participants experienced symptoms of unsteadiness during remission. 13/26 of participants reported persistent, though less annoying tinnitus that poorly correlated with THI score during remission. Conclusion: Our study showed that significant non-vertigo symptoms affect the quality of life during remission. Perhaps there is need to properly define, in future studies, what constitutes remission in patients with MD.
    Źródło:
    Polish Journal of Otolaryngology; 2020, 74, 4; 31-36
    0030-6657
    2300-8423
    Pojawia się w:
    Polish Journal of Otolaryngology
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Endolymphatic Hydrops, Evaluated Using 3T MRI in Patients with Clinically Confirmed Meniere Disease
    Autorzy:
    Jasińska, Agnieszka
    Wnuk, Emilia
    Pierchała, Katarzyna
    Niemczyk, Kazimierz
    Powiązania:
    https://bibliotekanauki.pl/articles/1399638.pdf
    Data publikacji:
    2019
    Wydawca:
    Index Copernicus International
    Tematy:
    endolymphatic hydrops
    inner ear magnetic resonanse
    Méniere’s disease
    Opis:
    Ménière’s disease (MD) is characterised by intermittent episodes of vertigo with fluctuating sensorineural hearing loss, tinnitus and aural fullness. Despite numerous studies, the etiology of this disorder remains poorly understood and thus diagnostic criteria are mainly clinical. Development and progress in magnetic resonance imaging (MRI) techniques, in 2007, has enabled visualisation of endolymphatic hydrops, which was the milestone achievement. We present two cases of patients with clinically confirmed MD with a set of audiological, otoneurological examinations and MRI performed. Structures of the inner ear were visualized using contrast-enhanced MR imaging after a 4-hour delayed intravenous gadolinium administration. The cochlea and vestibule were evaluated separately and classified using Barath grading scale. Endolymphatic hydrops in the clinically affected ears were confirmed using MRI. Due to disabling and intractable MD, a decision about vestibular neurectomy was made.
    Źródło:
    Polski Przegląd Otorynolaryngologiczny; 2019, 8, 3; 20-23
    2084-5308
    2300-7338
    Pojawia się w:
    Polski Przegląd Otorynolaryngologiczny
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Magnetic resonance imaging of the inner ear in the diagnostics of Ménière’s disease
    Autorzy:
    Jasińska, Agnieszka
    Lachowska, Magdalena
    Wnuk, Emilia
    Niemczyk, Kazimierz
    Powiązania:
    https://bibliotekanauki.pl/articles/1397271.pdf
    Data publikacji:
    2021
    Wydawca:
    Index Copernicus International
    Tematy:
    Ménière's disease
    endolymphatic hydrops
    magnetic resonance imaging
    hearing loss
    dizziness
    vertigo
    Opis:
    Ménière’s disease is characterized by sudden episodes of vertigo accompanied by tinnitus and/or feeling of fullness in the ear as well as fluctuating sensorineural hearing loss. Despite numerous studies, the etiology of this disease remains unknown. However, the enlargement of the inner ear’s endolymphatic spaces, referred to as endolymphatic hydrops, is considered the underlying condition. Thanks to recent advances in magnetic resonance (MR) technology, it is now possible to obtain in vivo imaging of endolymphatic hydrops in patients presenting with Ménière’s disease symptoms. Visualization of the inner ear fluid compartments is achieved after gadolinium contrast is administered into the tympanic cavity or via the intravenous route. Evaluation of endolymphatic hydrops is possible as the contrast agent selectively penetrates the perilymph, and endolymph is visualized as contrast defects. The currently used radiological hydrops grading systems include qualitative, semi-quantitative, and volumetric scales. The methods are subject to ongoing modifications to increase their sensitivity and specificity. Numerous studies describe correlations between clinical symptoms and audiological and otoneurological examination results with the endolymphatic hydrops grade. MRI is also applicable in patients’ diagnostics with an incomplete or atypical course of the Ménière’s disease. In the course of the treatment, follow-up MRI scans enable assessing individual treatment modalities’ efficacy in terms of the severity of lesions and the further course of the disease within the inner ear.
    Źródło:
    Polish Journal of Otolaryngology; 2021, 75, 2; 1-8
    0030-6657
    2300-8423
    Pojawia się w:
    Polish Journal of Otolaryngology
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Intratympanic injection of dexamethasone for Menière’s disease. What relief can be expected? A case-series study
    Autorzy:
    Plainfossé, Olivier
    El Yagoubi, Mohamed
    Puechmaille, Mathilde
    Mom, Thierry
    Powiązania:
    https://bibliotekanauki.pl/articles/1398960.pdf
    Data publikacji:
    2021
    Wydawca:
    Index Copernicus International
    Tematy:
    Dexamethasone
    intratympanic injections
    Menière’s disease
    tinnitus
    vertigo
    Opis:
    Introduction: In patients suffering from Menière’s disease (MD), after failure of oral medical treatment, intratympanic in-jections (IT) may be achieved, among which, IT with dexamethasone (DXM). IT DXM has been reported to be effective on vestibular symptoms but very few reports focus on auditory symptoms. Aim: Here we assessed its efficacy both in vestibular and auditory symptoms.Patients and method: Twenty-seven MD patients who suffered from auditory and vestibular symptoms despite previous sys-temic medical treatment, underwent at least one series of five daily consecutive IT DXM. Auditory and vestibular assessment were achieved before IT DXM, and four months afterwards. Patients were ranked according to the vestibular functional level scale of the American Academy of Otolaryngology Head Neck society (1995) at the same periods. A specifically designed qu-estionnaire, focused on auditory symptoms was administered after IT DXM. Comparisons used a Chi-2 test for paired series, with p ≤ 0.05 considered significant.Results: The vestibular functional level shifted significantly towards lower levels, the median shifting from level 4 to 3. There was no complication but two persistent tympanic membrane perforation. Twelve patients (44.4%) had recurrent symptoms, on average 7 months after IT DXM and required additional treatment. Tonal and speech audiometry did not improve, neither the objective auditory and vestibular assessment. Based on the questionnaire, IT DXM was effective on auditory symptoms, at least on tinnitus in 9 cases (33.3%), mainly by lowering its intensity.Conclusion: IT DXM confirmed its capacity to relieve vestibular and auditory symptoms, in particular tinnitus, even though transiently.
    Źródło:
    Polski Przegląd Otorynolaryngologiczny; 2021, 10, 1; 9-17
    2084-5308
    2300-7338
    Pojawia się w:
    Polski Przegląd Otorynolaryngologiczny
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Ménière’s disease pt. 2. Treatment options and therapeutic strategies. Commentary to the current recommendations and own experience
    Autorzy:
    Niemczyk, Kazimierz
    Jasińska, Agnieszka
    Pierchała, Katarzyna
    Powiązania:
    https://bibliotekanauki.pl/articles/1399075.pdf
    Data publikacji:
    2020
    Wydawca:
    Index Copernicus International
    Tematy:
    endolymphatic hydrops
    guidelines
    Ménière’s disease
    neurotology
    vertigo
    Opis:
    We present an overview of current diagnostic and therapeutic guidelines on Ménière’s disease. Over the last five years, several guidelines and studies on this subject have been published, including The International consensus (ICON) on treatment of Méniere’s disease of 2018, The European Position Statement on Diagnosis, and Treatment of Ménière’s Disease, The Diagnostic and therapeutic strategy in Menière’s disease. Guidelines of the French Otorhinolaryngology-Head and Neck Surgery Society (SFORL) of 2017 . Consequently, also the “American Academy of Otorhinolaryngology, Head and Neck Surgery” (AAO-HNS) published updated recommendations on the subject in April 2020. On the basis of these studies and a literature review, the main treatment methods used in Ménière’s disease and an assessment of their effectiveness were presented. The current recommendations, as well as own experience of the Clinic of Otorhinolaryngology, Head and Neck Surgery of the Medical University of Warsaw, gave grounds for proposing a therapeutic scheme.
    Źródło:
    Polski Przegląd Otorynolaryngologiczny; 2020, 9, 2; 18-22
    2084-5308
    2300-7338
    Pojawia się w:
    Polski Przegląd Otorynolaryngologiczny
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Distortion-product otoacoustic emission phase shift test (Shift-DPOAE) – methodology of measurements and interpretation of results in example cases
    Przesunięcie w fazie otoemisji akustycznych produktów zniekształceń nieliniowych ślimaka (Shift-DPOAE) – metodologia badania i interpretacja wyników na przykładach
    Autorzy:
    Lachowska, Magdalena
    Prus-Ostaszewska, Monika
    Niemczyk, Kazimierz
    Powiązania:
    https://bibliotekanauki.pl/articles/1399172.pdf
    Data publikacji:
    2020
    Wydawca:
    Index Copernicus International
    Tematy:
    distortion-product otoacoustic emission
    hearing loss
    Meniere’s disease
    phase shift
    tinnitus
    vertigo
    choroba Meniere’a
    niedosłuch
    otoemisje akustyczne
    przesunięcie w fazie
    szum uszny
    zawroty głowy
    Opis:
    Objective: The objective of the study was to present the methodology and interpretation of the results of distortion-product otoacoustic emission phase shift (Shift-DPOAE) measurements in healthy subjects and patients with Meniere’s disease in remission or during the attack. Material and methods: Shift-DPOAE measurements were performed in two healthy subjects with no otological or neurological problems as well as in six patients diagnosed with Meniere’s disease. Results obtained from all eight subjects are presented. Detailed otoscopy, impedance audiometry, pure tone audiometry, DPOAE, and Shift-DPOAE tests were performed in all subjects. Results: Normal results of Shift-DPOAE measurements obtained from two healthy subjects as well as normal (two subjects) and abnormal (four subjects) Shift-DPOAE results obtained from patients with Meniere’s disease are presented in order to thoroughly discuss the methodology and interpretation of Shift-DPOAE measurements. Conclusions: Shift-OAE is a promising diagnostic tool with a great clinical potential for diagnostics and monitoring of Meniere’s disease in patients whose hearing has not yet been damaged. The test is completely non-invasive and can be carried out immediately after the onset of disease attack with symptoms still present at the time of the test; in addition, the procedure takes just several minutes.
    Cel: Przedstawienie metodologii badania oraz prezentacja wyników przesunięcia w fazie otoemisji akustycznych produktów zniekształceń nieliniowych ślimaka (Shift-DPOAE), wykonanego u osób zdrowych i z potwierdzoną chorobą Meniere’a w fazie remisji oraz w ostrej fazie choroby w czasie ataku. Materiał i metody: Badanie Shift-DPOAE zostało wykonane u dwóch osób z prawidłowym słuchem i bez żadnych problemów otologicznych i neurologicznych (osoby zdrowe) oraz u sześciu z klinicznie zdiagnozowaną chorobą Meniere’a. W sumie w pracy prezentowano wyniki uzyskane u ośmiu osób. U wszystkich badanych wykonano następujące badania: dokładną otoskopię, audiometrię impedancyjną, audiometrię tonalną, tradycyjne badanie DPOAE oraz Shift-DPOAE. Wyniki: Zaprezentowano i omówiono prawidłowe wyniki Shift-DPOAE uzyskane u dwóch osób zdrowych oraz wyniki prawidłowe (dwie osoby) i nieprawidłowe (cztery osoby) uzyskane u pacjentów z chorobą Meniere’a, w celu dokładnego omówienia metodologii i interpretacji badania Shift-DPOAE. Wnioski: Shift-OAE to obiecujące badanie z dużym potencjałem klinicznym w diagnostyce i monitorowaniu choroby Meniere’a u pacjentów, u których słuch nie został jeszcze uszkodzony. Jest ono całkowicie nieinwazyjne, może być przeprowadzone zaraz po ataku choroby w trakcie trwania objawów, a jego wykonanie zajmuje zaledwie klika minut.
    Źródło:
    Polski Przegląd Otorynolaryngologiczny; 2020, 9, 1; 1-5
    2084-5308
    2300-7338
    Pojawia się w:
    Polski Przegląd Otorynolaryngologiczny
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies